These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 31129050)
1. Systemic delivery of Eg5 shRNA-expressing plasmids using PEGylated DC-Chol/DOPE cationic liposome: Long-term silencing and anticancer effects in vivo. Seraj S; Lee J; Ahn HJ Biochem Pharmacol; 2019 Aug; 166():192-202. PubMed ID: 31129050 [TBL] [Abstract][Full Text] [Related]
2. PEGylated DC-Chol/DOPE cationic liposomes containing KSP siRNA as a systemic siRNA delivery Carrier for ovarian cancer therapy. Lee J; Ahn HJ Biochem Biophys Res Commun; 2018 Sep; 503(3):1716-1722. PubMed ID: 30049442 [TBL] [Abstract][Full Text] [Related]
3. DC-Chol/DOPE cationic liposomes: a comparative study of the influence factors on plasmid pDNA and siRNA gene delivery. Zhang Y; Li H; Sun J; Gao J; Liu W; Li B; Guo Y; Chen J Int J Pharm; 2010 May; 390(2):198-207. PubMed ID: 20116418 [TBL] [Abstract][Full Text] [Related]
4. siRNA delivery to lung-metastasized tumor by systemic injection with cationic liposomes. Hattori Y; Nakamura A; Arai S; Kawano K; Maitani Y; Yonemochi E J Liposome Res; 2015; 25(4):279-86. PubMed ID: 25543847 [TBL] [Abstract][Full Text] [Related]
5. Dual antitumoral potency of EG5 siRNA nanoplexes armed with cytotoxic bifunctional glutamyl-methotrexate targeting ligand. Lee DJ; Kessel E; Edinger D; He D; Klein PM; Voith von Voithenberg L; Lamb DC; Lächelt U; Lehto T; Wagner E Biomaterials; 2016 Jan; 77():98-110. PubMed ID: 26584350 [TBL] [Abstract][Full Text] [Related]
6. Cytoplasmic expression of EGFR shRNA using a modified T7 autogene-based hybrid mRNA/DNA system induces long-term EGFR silencing and prolongs antitumor effects. Seraj S; Cho YJ; Lee JW; Ahn HJ Biochem Pharmacol; 2020 Jan; 171():113735. PubMed ID: 31786264 [TBL] [Abstract][Full Text] [Related]
7. Follicle-stimulating hormone peptide-conjugated nanoparticles for targeted shRNA delivery lead to effective gro-α silencing and antitumor activity against ovarian cancer. Hong SS; Zhang MX; Zhang M; Yu Y; Chen J; Zhang XY; Xu CJ Drug Deliv; 2018 Nov; 25(1):576-584. PubMed ID: 29461120 [TBL] [Abstract][Full Text] [Related]
8. Complexes containing cationic and anionic pH-sensitive liposomes: comparative study of factors influencing plasmid DNA gene delivery to tumors. Chen Y; Sun J; Lu Y; Tao C; Huang J; Zhang H; Yu Y; Zou H; Gao J; Zhong Y Int J Nanomedicine; 2013; 8():1573-93. PubMed ID: 23637529 [TBL] [Abstract][Full Text] [Related]
9. Thermodynamic aspects and biological profile of CDAN/DOPE and DC-Chol/DOPE lipoplexes. Keller M; Jorgensen MR; Perouzel E; Miller AD Biochemistry; 2003 May; 42(20):6067-77. PubMed ID: 12755608 [TBL] [Abstract][Full Text] [Related]
10. Small interfering RNA delivery into the liver by cationic cholesterol derivative-based liposomes. Hattori Y; Machida Y; Honda M; Takeuchi N; Yoshiike Y; Ohno H; Onishi H J Liposome Res; 2017 Dec; 27(4):264-273. PubMed ID: 27345333 [TBL] [Abstract][Full Text] [Related]
11. A T7 autogene-based hybrid mRNA/DNA system for long-term shRNA expression in cytoplasm without inefficient nuclear entry. Kwak SY; Han HD; Ahn HJ Sci Rep; 2019 Feb; 9(1):2993. PubMed ID: 30816180 [TBL] [Abstract][Full Text] [Related]
12. Liposomes co-Loaded with 6-Phosphofructo-2-Kinase/Fructose-2, 6-Biphosphatase 3 (PFKFB3) shRNA Plasmid and Docetaxel for the Treatment of non-small Cell Lung Cancer. Chowdhury N; Vhora I; Patel K; Doddapaneni R; Mondal A; Singh M Pharm Res; 2017 Nov; 34(11):2371-2384. PubMed ID: 28875330 [TBL] [Abstract][Full Text] [Related]
13. RNA interference-mediated silencing of focal adhesion kinase inhibits growth of human malignant glioma xenograft in nude mice. Wang GJ; Ma YP; Yang Y; Zhang N; Wang W; Liu SY; Chen LJ; Jiang Y; Zhao X; Wei YQ; Deng HX Cell Biol Int; 2011 Aug; 35(8):841-8. PubMed ID: 21247411 [TBL] [Abstract][Full Text] [Related]
14. Co-administration of liposomal l-OHP and PEGylated TS shRNA-lipoplex: A novel approach to enhance anti-tumor efficacy and reduce the immunogenic response to RNAi molecules. Alaaeldin E; Abu Lila AS; Ando H; Fukushima M; Huang CL; Wada H; Sarhan HA; Khaled KA; Ishida T J Control Release; 2017 Jun; 255():210-217. PubMed ID: 28461099 [TBL] [Abstract][Full Text] [Related]
15. Novel ortho ester-based, pH-sensitive cationic lipid for gene delivery in vitro and in vivo. Guo X; Gagne L; Chen H; Szoka FC J Liposome Res; 2014 Jun; 24(2):90-8. PubMed ID: 24188532 [TBL] [Abstract][Full Text] [Related]
16. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression. Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682 [TBL] [Abstract][Full Text] [Related]
17. Construction of simple and efficient DNA vector-based short hairpin RNA expression systems for specific gene silencing in mammalian cells. Cheng TL; Chang WT Methods Mol Biol; 2007; 408():223-41. PubMed ID: 18314586 [TBL] [Abstract][Full Text] [Related]
18. Effects of sterol derivatives in cationic liposomes on biodistribution and gene-knockdown in the lungs of mice systemically injected with siRNA lipoplexes. Hattori Y; Saito H; Oku T; Ozaki KI Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34165169 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of VEGF expression in A431 and MDA-MB-231 tumour cells by cationic lipid-mediated siRNA delivery. Briane D; Slimani H; Tagounits A; Naejus R; Haddad O; Coudert R; Charnaux N; Cao A J Drug Target; 2012 May; 20(4):347-54. PubMed ID: 22475204 [TBL] [Abstract][Full Text] [Related]
20. DNA vector-based RNA interference to study gene function in cancer. Stovall DB; Wan M; Zhang Q; Dubey P; Sui G J Vis Exp; 2012 Jun; (64):e4129. PubMed ID: 22710444 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]